The mission of TRB Chemedica Group is to develop innovative and patented pharmaceutical products and medical devices in niche therapeutic areas: rheumatology, ophthalmology and neurology.

Prolongation of the reimbursement of VISMED® and VISMED® MULTI in France

The French Ministry of Health prolongued the partial reimbursement of VISMED® and VISMED® MULTI, both containing a sterile solution of preservative-free 0.18% sodium hyaluronate for ophthalmic use in the symptomatic treatment of the Dry Eye.

VISMED® is the only preservative-free sodium hyaluronate-based lubricant eye drops reimbursed in France.



Enhanced protection in dry eye

VISMED® GEL  is a preservative-free viscoelastic solution for sustained lubrication of the eyes in case of sensations of dryness, burning or ocular fatigue induced by environmental conditions, extended computer screen use, contact lens wear or by ophthalmological screening methods.

VISMED® GEL  is a patented hypotonic formulation that contains both 0.30% sodium hyaluronate, a natural polymer which is also present in the structures of human eyes, and most of the essential ions that are present in natural tears.

VISMED® GEL  is available in boxes of 20 (or 60) reclosable single dose units of 0.45 ml.

pdf VISMED® GEL leaflet
trb_lock.gif Doctor information

  • English